1. Home
  2. BKR vs TAK Comparison

BKR vs TAK Comparison

Compare BKR & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baker Hughes Company

BKR

Baker Hughes Company

N/A

Current Price

$46.67

Market Cap

62.0B

Sector

Industrials

ML Signal

N/A

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

N/A

Current Price

$21.42

Market Cap

69.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BKR
TAK
Founded
2016
1781
Country
United States
Japan
Employees
64000
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.0B
69.1B
IPO Year
2017
2007

Fundamental Metrics

Financial Performance
Metric
BKR
TAK
Price
$46.67
$21.42
Analyst Decision
Buy
Strong Buy
Analyst Count
25
3
Target Price
★ $69.75
$24.57
AVG Volume (30 Days)
★ 8.8M
2.8M
Earning Date
10-27-2026
10-29-2026
Dividend Yield
★ 1.95%
1.13%
EPS Growth
★ 56.02
N/A
EPS
★ 2.98
N/A
Revenue
★ $27,733,000,000.00
N/A
Revenue This Year
$6.98
$4.79
Revenue Next Year
$10.25
$2.44
P/E Ratio
★ $15.83
$41.25
Revenue Growth
N/A
★ N/A
52 Week Low
$44.26
$14.09
52 Week High
$70.41
$21.86

Technical Indicators

Market Signals
Indicator
BKR
TAK
Relative Strength Index (RSI) 34.01 65.58
Support Level $46.03 $17.66
Resistance Level $65.24 $21.73
Average True Range (ATR) 2.02 0.33
MACD -0.17 -0.02
Stochastic Oscillator 5.29 68.48

Price Performance

Historical Comparison
BKR
TAK

About BKR Baker Hughes Company

Following a 2022 reorganization, Baker Hughes operates in two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment is one of the Big Three oilfield-services players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three-fourths of the segment's offerings. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services for various energy and industrial applications.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: